| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention relates to the method for production of the compound of the formula (1a), being an inhibitor of thrombocyte aggregation (1a), where X is halogen atom. The method includes interaction of compounds of the formula (II), (II), where X has above mentioned value and Y and Z independently from each other are leaving groups, with optically active alkamine with formation of diastereoisomers admixture. ^ EFFECT: development of the new advantageous method for production of the bioactive compound. ^ 48 cl, 24 ex |
